BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17368612)

  • 1. [Intrathecal baclofen in hereditary spastic paraparesis: benefits and limitations].
    Lambrecq V; Muller F; Joseph PA; Cuny E; Mazaux JM; Barat M
    Ann Readapt Med Phys; 2007 Oct; 50(7):577-81. PubMed ID: 17368612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal baclofen in hereditary spastic paraparesis.
    Meythaler JM; Steers WD; Tuel SM; Cross LL; Sesco DC; Haworth CS
    Arch Phys Med Rehabil; 1992 Sep; 73(9):794-7. PubMed ID: 1514885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of intrathecal baclofen in the treatment of spasticity in stroke].
    Lamotte D; Cantalloube S
    Ann Readapt Med Phys; 2007 Apr; 50(3):165-9. PubMed ID: 17145092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
    Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; Pittalà G; Castiglione A; Patti F; Mangiameli S
    Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
    Natale M; Mirone G; Rotondo M; Moraci A
    Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia.
    Margetis K; Korfias S; Boutos N; Gatzonis S; Themistocleous M; Siatouni A; Dalivigka Z; Flaskas T; Stranjalis G; Boviatsis E; Sakas D
    Clin Neurol Neurosurg; 2014 Aug; 123():142-5. PubMed ID: 24973568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intrathecal baclofen in a child with spastic paraparesis related to human immunodeficiency virus infection: A case report.
    Kolaski K
    Arch Phys Med Rehabil; 2006 Jul; 87(7):1001-3. PubMed ID: 16813790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal baclofen infusion for ambulant children with cerebral palsy.
    Brochard S; Remy-Neris O; Filipetti P; Bussel B
    Pediatr Neurol; 2009 Apr; 40(4):265-70. PubMed ID: 19302938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of spasticity therapy with baclofen pump in children].
    Swierczyńska A
    Przegl Lek; 2007; 64 Suppl 2():15-7. PubMed ID: 17953273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of spasticity with the intrathecal administration of baclofen].
    Lazorthes Y; Sallerin B; Verdié JC; Casaux J; Caraoué F; Sol JC
    Neurochirurgie; 1998 Sep; 44(3):201-8. PubMed ID: 9827437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional outcome of intrathecal baclofen administration for severe spasticity.
    Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
    Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
    Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic intrathecal baclofen in severely disabling spasticity: selection, clinical assessment and long-term benefit.
    Pirotte B; Heilporn A; Joffroy A; Zegers de Beyl D; Wesel P; Brotchi J; Levivier M
    Acta Neurol Belg; 1995 Dec; 95(4):216-25. PubMed ID: 8553795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GMFM 1 year after continuous intrathecal baclofen infusion.
    Krach LE; Kriel RL; Gilmartin RC; Swift DM; Storrs BB; Abbott R; Ward JD; Bloom KK; Brooks WH; Madsen JR; McLaughlin JF; Nadell JM
    Pediatr Rehabil; 2005; 8(3):207-13. PubMed ID: 16087555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life.
    Ivanhoe CB; Francisco GE; McGuire JR; Subramanian T; Grissom SP
    Arch Phys Med Rehabil; 2006 Nov; 87(11):1509-15. PubMed ID: 17084128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy.
    Bleyenheuft C; Filipetti P; Caldas C; Lejeune T
    Neurophysiol Clin; 2007; 37(1):23-8. PubMed ID: 17418354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of the effect of a bolus dose of intrathecal baclofen on severe cerebral spasticity.
    Pohl M; Rockstroh G; Rückriem S; Mehrholz J; Pause M; Koch R; Strik H
    J Neurol; 2003 Oct; 250(10):1195-200. PubMed ID: 14586601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The parents expectations after baclofen pump implantation in child with severe spasticity in physical rehabilitation and psychological aspects].
    Fafara A; Kwiatkowski S; Kawecka J; Grzegorzewski P; Kawecki Z
    Przegl Lek; 2007; 64 Suppl 2():18-21. PubMed ID: 17953274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.